<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02960451</url>
  </required_header>
  <id_info>
    <org_study_id>1411014943</org_study_id>
    <nct_id>NCT02960451</nct_id>
  </id_info>
  <brief_title>PRIME vs Usual Care for Clinical High Risk</brief_title>
  <official_title>Randomized Trial of Usual Care vs. Specialized, Phase-specific Care for Youth at Risk for Psychosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether specialty care is superior to usual care in
      the treatment of patients at clinical high risk for psychosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized clinical effectiveness trial for patients at clinical high risk
      for psychosis that compares two treatments: 1) specialty care delivered in a specialized
      clinical for patients at clinical high risk for psychosis versus 2) treatment as usual in the
      community.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Global Assessment of Functioning</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Service utilization</measure>
    <time_frame>24 months</time_frame>
    <description>hospitalizations and emergency room use</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Clinical High Risk Syndrome for Psychosis</condition>
  <arm_group>
    <arm_group_label>PRIME care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Specialized care in the PRIME clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual care in the community</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PRIME care</intervention_name>
    <description>Specialist medication, cognitive behavior therapy, family-focused therapy</description>
    <arm_group_label>PRIME care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Medication and psychotherapy as available form community providers</description>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must meet all of the following:

               1. Male or female between 12 and 30 years old.

               2. Understand and sign an informed consent (or assent for minors) document in
                  English.

               3. Meet diagnostic criteria for prodromal syndrome as per COPS criteria.

        Exclusion Criteria:

          -  Subjects must not meet any of the following:

               1. Diagnosis of current or lifetime Axis I psychotic disorder, including mood
                  disorder with psychotic symptoms.

               2. Impaired intellectual functioning (full-scale IQ&lt;70). However, those with an IQ
                  in the 65-69 range will not be excluded if they score &gt;75 on the WRAT Reading.

               3. Past or current history of a clinically significant central nervous system
                  disorder that may contribute to prodromal symptoms or confound their assessment.

               4. Alcohol or substance dependence in the past 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Woods, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Walsh, PhD</last_name>
    <phone>2039747052</phone>
    <email>barbara.walsh@yale.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Prevention through Risk Identification Management and Education (PRIME) Clinic</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Walsh, PhD</last_name>
      <phone>866-287-7463</phone>
      <email>barbara.walsh@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Scott W. Woods, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2016</study_first_submitted>
  <study_first_submitted_qc>November 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2016</study_first_posted>
  <last_update_submitted>November 8, 2016</last_update_submitted>
  <last_update_submitted_qc>November 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prodrome</keyword>
  <keyword>cognitive behavioral therapy</keyword>
  <keyword>family focused therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

